Aratana Therapeutics to Present at Bank of America Merrill Lynch Healthcare Conference

LEAWOOD, Kan., May 2, 2016 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals, will present at the Bank of America Merrill Lynch Healthcare Conference in Las Vegas on May 10, 2016 at 5:00 p.m. PT.

Aratana Therapeutics logo

A live webcast will be provided from the event. Interested parties may also access the webcast and view presentation slides for up to 90 days after the event in the Aratana Investor Room.

About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative pharmaceutical products for dogs and cats. Aratana believes that it can leverage the investment in the human pharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. The Company has multiple products approved by the Food and Drug Administration's Center for Veterinary Medicine or licensed by the United States Department of Agriculture. The Company's pipeline includes therapeutic candidates targeting pain, inappetence, cancer, viral diseases, allergy and other serious, unmet or underserved medical needs.  Aratana believes providing innovative options to veterinarians and pet owners will help manage pets' medical needs safely and effectively, result in longer and improved quality of life for pets. For more information, please visit

For investor inquires:
Craig Tooman 
(913) 353-1026

For media inquiries: 
Rachel Reiff 
(913) 353-1050

Logo - 

SOURCE Aratana Therapeutics, Inc.

print email rss